Stroke is a severe neurological event that can have long-term implications, including cognitive and motor deficits, long-term disability, and increased risk of recurrent stroke. Biomarkers such as neurofilament light (NfL), glial fibrillary acidic protein (GFAP), and tau proteins are particularly relevant to stroke research. Elevated levels of these biomarkers have been associated with neurological injury and can be used to assess the extent of damage and predict outcomes. Despite this elevation, biomarker levels remain low and require advanced technology with ultrasensitive measurement capabilities for accurate detection. Download our flyer to learn more and to view a sampling of peer-reviewed studies employing Simoa® technology for stroke research.